Share this [8]
The lead U.S. drug industry lobby group, the Pharmaceutical Research and Manufacturers of America [9] (PhRMA), spent $10.7 million in the first six months of 2007 lobbying the U.S. government. (In the preceding six-month period, PhRMA spent $8.8 million.) Associated Press reports that PhRMA'S latest lobbying report, required under the Lobbying Disclosure Act of 1995 [10], states that the group lobbied Congress, the U.S. Food and Drug Administration [11], the Department of Health and Human Services [12], and other agencies on "issues related to Medicare, patent reform, international trade and drug fees, importation and safety." Billy Tauzin [13], a former Republican member of the House of Representatives from Louisiana turned PhRMA chief executive, is one of the group's registered lobbyists.
Links:
[1] http://dev.prwatch.org/users/7/bob-burton
[2] http://dev.prwatch.org/topics/public-relations/issue-management
[3] http://dev.prwatch.org/topics/us-government/us-congress
[4] http://dev.prwatch.org/topics/corporations
[5] http://dev.prwatch.org/topics/health
[6] http://dev.prwatch.org/topics/lobbying
[7] http://dev.prwatch.org/topics/pharmaceuticals
[8] http://www.addtoany.com/share_save?linkurl=http%3A%2F%2Fdev.prwatch.org%2Fspin%2F2007%2F08%2F6366%2Fbig-spending-drug-industry-defenders&linkname=Big-Spending%20Drug%20Industry%20Defenders
[9] http://www.sourcewatch.org/index.php/Pharmaceutical_Research_and_Manufacturers_of_America
[10] http://www.sourcewatch.org/index.php/Lobbying_Disclosure_Act_of_1995
[11] http://www.sourcewatch.org/index.php/U.S._Food_and_Drug_Administration
[12] http://www.sourcewatch.org/index.php/Department_of_Health_and_Human_Services
[13] http://www.sourcewatch.org/index.php/Billy_Tauzin
[14] http://www.forbes.com/feeds/ap/2007/08/17/ap4031611.html